Investigation of gene expression in relation to omalizumab treatment and peanut oral immunotherapy
In conclusion, assessment of transcriptional changes following omalizumab treatment and pOIT in peanut allergy patients provides insights into mechanisms of allergen tolerance.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Merid, S. K., Björkander, S., Brodin, D., Brandström, J., Fagerström-Billai, F., Van Der Heiden, M., Konradsen, J., Kabesch, M., Van Drunen, C., Kornel, G., Maitland-Van Der Zee, A. H., Potocnik, U., Vijverberg, V. J. H., Nopp, A., Tags: Paediatric asthma and allergy Source Type: research
More News: Allergy | Allergy & Immunology | Anaphylactic Shock | Asthma | Children | Food Allergy | Genetics | Immunotherapy | Peanuts | Pediatrics | Respiratory Medicine | Xolair